Crossmark Global Holdings’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,290
| Closed | -$151K | – | 1338 |
|
|
2023
Q4 | $151K | Sell |
16,290
-19
| -0.1% | -$176 | ﹤0.01% | 1273 |
|
|
2023
Q3 | $161K | Buy |
16,309
+623
| +4% | +$6.15K | ﹤0.01% | 1221 |
|
|
2023
Q2 | $214K | Hold |
15,686
| – | – | ﹤0.01% | 1222 |
|
|
2023
Q1 | $183K | Buy |
15,686
+1,664
| +12% | +$19.4K | ﹤0.01% | 1246 |
|
|
2022
Q4 | $149K | Buy |
14,022
+434
| +3% | +$4.61K | ﹤0.01% | 1220 |
|
|
2022
Q3 | $132K | Buy |
13,588
+255
| +2% | +$2.48K | ﹤0.01% | 1209 |
|
|
2022
Q2 | $193K | Sell |
13,333
-1,700
| -11% | -$24.6K | 0.01% | 1222 |
|
|
2022
Q1 | $393K | Buy |
15,033
+8,843
| +143% | +$231K | 0.01% | 1017 |
|
|
2021
Q4 | $245K | Buy |
+6,190
| New | +$245K | 0.01% | 1252 |
|